Skip to main content
Top

04-10-2012 | Diabetic foot ulcers | Book chapter | Article

4. Clinical Examination and Risk Classification of the Diabetic Foot

Authors: Lawrence A. Lavery, DPM, MPH, David G. Armstrong, DPM, PhD

Publisher: Humana Press

Abstract

Foot ulceration is one of the most common precursors to lower extremity amputations among persons with diabetes (Singh et al., JAMA. 2005; 293(2):217–28; Boulton and Vileikyte, Wounds. 2000; 12(Suppl B):12B–8; Reiber et al., Rehabil Res Dev. 2001; 38(3):309–17). Ulcerations are pivotal events in limb loss for two important reasons. They allow an avenue for infection (Armstrong and Lipsky, Diabetes Technol Ther. 2004; 6:167–77), and they can cause progressive tissue necrosis and poor wound healing in the presence of critical ischemia. Infections involving the foot rarely develop in the absence of a wound in adults with diabetes, and ulcers are the most common type of wound in this population (Armstrong and Lipsky, Diabetes Technol Ther. 2004; 6:167–77). Foot ulcers, therefore, play a central role in the causal pathway to lower extremity amputation (Pecoraro et al., Diabetes Care. 1990; 13:513–21).
The etiology of ulcerations in persons with diabetes is commonly associated with the presence of peripheral neuropathy and repetitive trauma due to normal walking activities to areas of the foot exposed to moderate or high pressure and shear forces (Armstrong et al., J Foot Ankle Surg. 1998; 37(4):303–7). Foot deformities, limited joint mobility, partial foot amputations, and other structural deformities often predispose diabetics with peripheral neuropathy to abnormal weight bearing, areas of concentrated pressure, and abnormal shear forces that significantly increase their risk of ulceration (Cavanagh et al., Diabet Med. 1996; 13 Suppl 1:S17–22; Lavery et al., Diabetes Care. 1996; 19(8):818–21; Diabetes Care. 1995; 18(11):1460–2). Brand (The diabetic foot. In: Diabetes mellitus, theory and practice. Medical Examination) theorized that when these types of forces were applied to a discrete area over an extended period they would cause a local inflammatory response, focal tissue ischemia, tissue destruction, and ulceration. Clearly, identification of persons at risk for ulceration is of central importance in any plan for amputation prevention and diabetes care.
Literature
1.
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217–28.PubMedCrossRef
2.
Boulton AJM, Vileikyte L. Pathogenesis of diabetic foot ulceration and measurements of neuropathy. Wounds. 2000;12(Suppl B):12B–8.
3.
Reiber GE, Smith DG, Carter J, et al. A comparison of diabetic foot ulcer patients managed in VHA and non-VHA settings. J Rehabil Res Dev. 2001;38(3):309–17.PubMed
4.
Armstrong DG, Lipsky BA. Advances in the treatment of diabetic foot infections. Diabetes Technol Ther. 2004;6:167–77.PubMedCrossRef
5.
Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 1990;13:513–21.PubMedCrossRef
6.
Armstrong DG, Peters EJ, Athanasiou KA, Lavery LA. Is there a critical level of plantar foot pressure to identify patients at risk for neuropathic foot ulceration? J Foot Ankle Surg. 1998;37(4):303–7.PubMedCrossRef
7.
Cavanagh PR, Ulbrecht JS, Caputo GM. Biomechanical aspects of diabetic foot disease: aetiology, treatment, and prevention. Diabet Med. 1996;13 Suppl 1:S17–22.PubMed
8.
Lavery LA, Vela SA, Lavery DC, Quebedeaux TL. Reducing dynamic foot pressures in high-risk diabetic subjects with foot ulcerations. A comparison of treatments. Diabetes Care. 1996;19(8):818–21.PubMedCrossRef
9.
Lavery LA, Lavery DC, Quebedeax-Farnham TL. Increased foot pressures after great toe amputation in diabetes. Diabetes Care. 1995;18(11):1460–2.PubMedCrossRef
10.
Brand PW. The diabetic foot. In: Ellenberg M, Rifkin H, editors. Diabetes mellitus, theory and practice. 3rd ed. New York: Medical Examination; 1983. p. 803–28.
11.
Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med. 1998;158:158–62.CrossRef
12.
Uccioli L, Faglia E, Monticone G, et al. Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care. 1995;18(10):1376–8.PubMedCrossRef
13.
International working group on the diabetic foot. International Consensus on the Diabetic Foot. Maastricht: International Working Group on the Diabetic Foot; 1999.
14.
Peters EJ, Lavery LA. Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care. 2001;24(8):1442–7.PubMedCrossRef
15.
Mayfield JA, Reiber GE, Nelson RG, Greene T. A foot risk classification system to predict diabetic amputation in Pima Indians. Diabetes Care. 1996;19(7):704–9.PubMedCrossRef
16.
Rith-Najarian S, Branchaud C, Beaulieu O, Gohdes D, Simonson G, Mazze R. Reducing lower-extremity amputations due to diabetes. Application of the staged diabetes management approach in a primary care setting. J Fam Pract. 1998;47(2):127–32.PubMed
17.
Armstrong DG, Lavery LA, Harkless LB. Who’s at risk for diabetic foot ulceration? Clin Podiatr Med Surg. 1998;15:11–9.PubMed
18.
Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care. 1999;22(7):1036–42.PubMedCrossRef
19.
Abbott CA, Carrington AL, Ashe H, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19(5):377–84.PubMedCrossRef
20.
Goldner MG. The fate of the second leg in the diabetic amputee. Diabetes. 1960;9:100–3.PubMed
21.
Lavery LA, Peters EJ, Williams JR, Murdoch DP, Hudson A, Lavery DC. Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diabetes Care. 2008;31(1):154–6.PubMedCrossRef
22.
Helm PA, Walker SC, Pulliam GF. Recurrence of neuropathic ulcerations following healing in a total contact cast. Arch Phys Med Rehabil. 1991;72(12):967–70.PubMed
23.
Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Intern Med. 1998;158:289–92.PubMedCrossRef
24.
Quebedeaux TL, Lavery LA, Lavery DC. The development of foot deformities and ulcers after great toe amputation in diabetes. Diabetes Care. 1996;19(2):165–7.PubMedCrossRef
25.
Murdoch DP, Armstrong DG, Dacus JB, Laughlin TJ, Morgan CB, Lavery LA. The natural history of great toe amputations. J Foot Ankle Surg. 1997;36(3):204–8.PubMedCrossRef
26.
Reiber GE, Vileikyte L, Boyko EJ, et al. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. Diabetes Care. 1999;22(1):157–62.PubMedCrossRef
27.
Olaleye D, Perkins BA, Bril V. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Pract. 2001;54(2):115–28.PubMedCrossRef
28.
Liniger C, Albeanu A, Bloise D, Assal JP. The tuning fork revisited. Diabet Med. 1990;7(10):859–64.PubMedCrossRef
29.
Kastenbauer T, Sauseng S, Brath H, Abrahamian H, Irsigler K. The value of the Rydel-Seiffer tuning fork as a predictor of diabetic polyneuropathy compared with a neurothesiometer. Diabet Med. 2004;21(6):563–7.PubMedCrossRef
30.
Thivolet C, el Farkh J, Petiot A, Simonet C, Tourniaire J. Measuring vibration sensations with graduated tuning fork. Simple and reliable means to detect diabetic patients at risk of neuropathic foot ulceration. Diabetes Care. 1990;13(10):1077–80.PubMedCrossRef
31.
Armstrong DG. The 10-g monofilament: the diagnostic divining rod for the diabetic foot? Diabetes Care. 2000;23(7):887 [Editorial].PubMedCrossRef
32.
Sorman E, Edwall LL. [Examination of peripheral sensibility. Vibration test is more sensitive than monofilament test]. Lakartidningen. 2002;99(12):1339–40.PubMed
33.
Gin H, Rigalleau V, Baillet L, Rabemanantsoa C. Comparison between monofilament, tuning fork and vibration perception tests for screening patients at risk of foot complication. Diabetes Metab. 2002;28(6 Pt 1):457–61.PubMed
34.
Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at risk for lower extremity amputation in a primary health care setting. Diabetes Care. 1992;15(10):1386–9.PubMedCrossRef
35.
Pham HT, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify the at risk patients for developing diabetic foot ulcers in a prospective multicenter trial. Diabetes Care. 2000;23:606–11.PubMedCrossRef
36.
Yong R, Karas TJ, Smith KD, Petrov O. The durability of the Semmes-Weinstein 5.07 monofilament. J Foot Ankle Surg. 2000;39(1):34–8.PubMedCrossRef
37.
Booth J, Young MJ. Differences in the performance of commercially available 10-g monofilaments. Diabetes Care. 2000;23(7):984–8.PubMedCrossRef
38.
Ulbrecht JS, Cavanagh PR, Caputo GM. Foot problems in diabetes: an overview. Clin Infect Dis. 2004;39 Suppl 2:S73–82.PubMedCrossRef
39.
Mueller MJ. Identifying patients with diabetes who are at risk for lower extremity complications: use of Semmes-Weinstein monofilaments. Phys Ther. 1996;76(1):68–71.PubMed
40.
Smieja M. Clinical examination for the detection of protective sensation in the feet of diabetic patients. International Cooperative Group for Clinical Examination Research. J Gen Intern Med. 1999;14(7):418–24.PubMedCrossRef
41.
Armstrong DG. Loss of protective sensation: a practical evidence-based definition. J Foot Ankle Surg. 1999;38(1):79–80.PubMedCrossRef
42.
Abbott CA, Vileikyte L, Williamson S, Carrington AL, Boulton AJ. Multicenter study of the incidence of and predictive risk factors for diabetic neuropathic foot ulceration. Diabetes Care. 1998;21(7):1071–5.PubMedCrossRef
43.
Mason J, O’Keeffe C, Hutchinson A, McIntosh A, Young R, Booth A. A systematic review of foot ulcer in patients with Type 2 diabetes mellitus. II: treatment. Diabet Med. 1999;16(11):889–909.PubMedCrossRef
44.
Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care. 1994;17(6):557–60.PubMedCrossRef
45.
Boulton AJM. The importance of abnormal foot pressure and gait in causation of foot ulcers. In: Connor H, Boulton AJM, Ward JD, editors. The foot in diabetes. 1st ed. Chilchester: Wiley; 1987. p. 11–26.
46.
Duckworth T, Betts RP, Franks CI, Burke J. The measurement of pressure under the foot. Foot Ankle. 1982;3:130.PubMed
47.
Birke JA, Novick A, Graham SL, Coleman WC, Brasseaux DM. Methods of treating plantar ulcers. Phys Ther. 1991;71(2):116–22.PubMed
48.
Veves A, Murray HJ, Young MJ, Boulton AJM. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetolgica. 1992;35:660–3.CrossRef
49.
Grant WP, Sullivan R, Sonenshine DE, et al. Electron microscopic investigation of the effects of diabetes mellitus on the Achilles tendon. J Foot Ankle Surg. 1997;36(4):272–8; discussion 330.PubMedCrossRef
50.
Rosenbloom AL, Silverstein JH, Lezotte DC, Riley WJ, Maclaren NK. Limited joint mobility in diabetes mellitus of childhood: natural history and relationship to growth impairment. J Pediatr. 1982;101(5):874–8.PubMedCrossRef
51.
Rosenbloom AL. Skeletal and joint manifestations of childhood diabetes. Pediatr Clin North Am. 1984;31:569–89.PubMed
52.
Birke JA, Franks D, Foto JG. First ray joint limitation, pressure, and ulceration of the first metatarsal head in diabetes mellitus. Foot Ankle. 1995;16(5):277–84.PubMed
53.
Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care. 1998;21(10):1714–9 [In Process Citation].PubMedCrossRef
54.
Fernando DJS, Masson EA, Veves A, Boulton AJM. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care. 1991;14:8–11.PubMedCrossRef
55.
Armstrong DG, Stacpoole-Shea S, Nguyen HC, Harkless LB. Lengthening of the Achilles tendon in diabetic patients who are at high risk for ulceration of the foot. J Bone Joint Surg Am. 1999;81A:535–8.
56.
Birke J, Cornwall MA, Jackson M. Relationship between hallux limitus and ulceration of the great toe. J Orthop Sports Phys Ther. 1988;10:172–6.PubMed
57.
Grayson ML, Balaugh K, Levin E, Karchmer AW. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. J Am Med Assoc. 1995;273(9):721–3.CrossRef
58.
Birke JA, Novick A, Patout CA, Coleman WC. Healing rates of plantar ulcers in leprosy and diabetes. Lepr Rev. 1992;63(4):365–74.PubMed
59.
Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus: a case control study. Ann Intern Med. 1992;117(2):97–105.PubMed
60.
Wunderlich RP, Peters EJ, Armstrong DG, Lavery LA. Reliability of digital videometry and acetate tracing in measuring the surface area of cutaneous wounds. Diabetes Res Clin Pract. 2000;49(2–3):87–92.PubMedCrossRef
61.
Oyibo SO, Jude EB, Tarawneh I, et al. A comparison of two diabetic foot ulcer classification systems. Diabetes. 2000;49 Suppl 1:A33.
62.
Armstrong DG, Lavery LA, Harkless LB. Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation [see comments]. Diabetes Care. 1998;21(5):855–9.PubMedCrossRef
63.
Armstrong DG, Peters EJ. Classification of wounds of the diabetic foot. Curr Diab Rep. 2001;1:233–8.PubMedCrossRef
64.
Meggitt B. Surgical management of the diabetic foot. Br J Hosp Med. 1976;16:227–332.
65.
Wagner FW. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981;2:64–122.PubMed
66.
Smith RG. Validation of Wagner’s classification: a literature review. Ostomy Wound Manage. 2003;49(1):54–62.PubMed
67.
Calhoun JH, Cantrell J, Cobos J, et al. Treatment of diabetic foot infections: Wagner classification, therapy, and outcome. Foot Ankle. 1988;9:101–6.PubMed
68.
Van Acker K. The diabetic foot. A challenge for policy-makers and health care professionals. Antwerp: Department of Medicine, University of Antwerp; 2000.
69.
Forrest RD, Gamborg-Neilsen P. Wound assessment in clinical practice: a critical review of methods and their application. Acta Med Scand. 1984;687:69–74.
70.
Pecoraro RE, Reiber GE. Classification of wounds in diabetic amputees. Wounds. 1990;2(2):65–73.
71.
Arlt B, Protze J. [Diabetic foot]. Langenbecks Arch Chir Suppl Kongressbd. 1997;114:528–32.PubMed
72.
Knighton DR, Ciresi KF, Fiegel VD, Austin LL, Butler EL. Classification and treatment of chronic nonhealing wounds: successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg. 1986;204:322–30.PubMedCrossRef
73.
Schaper NC. Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies. Diabetes Metab Res Rev. 2004;20 Suppl 1:S90–5.PubMedCrossRef
74.
Macfarlane RM, Jeffcoate WJ. Classification of diabetic foot ulcers: the S(AD) SAD system. Diabet Foot. 1999;2(4):123–31.
75.
Jeffcoate WJ, Macfarlane RM, Fletcher EM. The description and classification of diabetic foot lesions. Diabet Med. 1993;10:676–9.PubMedCrossRef
76.
Lavery LA, Armstrong DG, Harkless LB. Classification of diabetic foot wounds. J Foot Ankle Surg. 1996;35(6):528–31.PubMedCrossRef
77.
Caputo GM. Infection: investigation and management. In: Boulton AJM, Connor H, Cavanagh PR, editors. The foot in diabetes. 2nd ed. Chichester: Wiley; 1994.
78.
LoGerfo FW, Coffman JD. Vascular and microvascular disease of the foot in diabetes. N Engl J Med. 1984;311:1615–9.PubMedCrossRef
79.
Bacharach J, Rooke T, Osmundson P, Glovizzki P. Predictive value of trascutaneous oxygen pressure and amputation success by use of supine and elevation measurements. J Vasc Surg. 1992;15:558–63.PubMedCrossRef
80.
Carter S. Elective foot surgery in limbs with arterial disease. Clin Orthop. 1993;289:228–36.PubMed
81.
Apelqvist J, Castenfors J, Larsson J. Prognostic value of ankle and toe blood pressure levels in outcome of diabetic foot ulcers. Diabetes Care. 1989;12:373–8.PubMedCrossRef
82.
Orchard TJ, Strandness DE. Assessment of peripheral vascular disease in diabetes: report and recommendation of an international workshop. Diabetes Care. 1993;83(12):685–95.
83.
Joseph WS. Handbook of Lower Extremity Infections. 1st ed. New York: Churchill Livingston; 1990.
84.
Lavery LA, Armstrong DG, Quebedeaux TL, Walker SC. Puncture wounds: the frequency of normal laboratory values in the face of severe foot infections of the foot in diabetic and non-diabetic adults. Am J Med. 1996;101:521–5.PubMedCrossRef
85.
Molinar DM, Palumbo PH, Wilson WR, Ritts RE. Leukocyte chemotaxis in diabetic patients and their first degree relatives. Diabetes. 1976;25:880–9.
86.
Bagdade JD, Root RK, Bulger RJ. Impaired leukocyte function in patients with poorly controlled diabetes. Diabetes. 1974;23:9–17.PubMed
87.
Tan JS, Anderson JL, Watanakunakorn C, Phair JP. Neutrophil dysfunction in diabetes mellitus. J Lab Clin Med. 1975;85:26–33.PubMed
88.
Armstrong DG, Lavery LA, Sariaya M, Ashry H. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg. 1996;35(4):280–3.PubMedCrossRef
89.
Armstrong DG, Perales TA, Murff RT, Edelson GW, Welchon JG. Value of white blood cell count with differential in the acute diabetic foot infection. J Am Podiatr Med Assoc. 1996;86(5):224–7.PubMed
90.
Armstrong DG, Lavery LA, Liswood PJ, Todd WF, Tredwell JA. Infrared dermal thermometry for the high-risk diabetic foot. Phys Ther. 1997;77(2):169–75; discussion 176–167.PubMed
91.
Armstrong DG, Liswood PJ, Todd WF, William J. 1995 William J. Prevalence of mixed infections in the diabetic pedal wound. A retrospective review of 112 infections. J Am Podiatr Med Assoc. 1995;85(10):533–7.PubMed
92.
Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJ. A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classification systems. Diabetes Care. 2001;24(1):84–8.PubMedCrossRef

Be confident that your patient care is up to date

Medicine Matters is being incorporated into Springer Medicine, our new medical education platform. 

Alongside the news coverage and expert commentary you have come to expect from Medicine Matters diabetes, Springer Medicine's complimentary membership also provides access to articles from renowned journals and a broad range of Continuing Medical Education programs. Create your free account »